Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bifendate

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Biphenyl Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Protective Effect of Eckol against Acute Hepatic Injury Induced by Carbon Tetrachloride in Mice
Several in vitro studies have shown the potential hepatoprotective properties of eckol, a natural phlorotannin derived from the… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2017
2017
Characterizations and hepatoprotective effect of polysaccharides from Mori Fructus in rats with alcoholic-induced liver injury.
Crude polysaccharides of Mori Fructus (MFPs) were found to have anti-inflammatory antioxidant, and immuno-enhancing activities… Expand
  • table 1
  • table 2
2013
2013
Comparative study of the binding of Trypsin with bifendate and analogs by spectrofluorimetry.
The interactions between Trypsin and bifendate (DDB) or analogs (I, II and III) were investigated by fluorescence, UV-visible… Expand
2012
2012
Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion
Objective: The aim of this study was to evaluate several polymer carriers with regard to the bioavailability enhancement of… Expand
2012
2012
Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potent P-glycoprotein inhibitors.
Overexpression of P-glycoprotein (P-gp) is one of the major problems in successful treatment of cancers. To find new P-gp… Expand
2012
2012
Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors.
Overexpression of P-glycoprotein (P-gp) is one of the major problems to successful cancer chemotherapy. To find novel effective P… Expand
2011
2011
Preparation, characterization and biodistribution of nanostructured lipid carriers for parenteral delivery of bifendate
Nanostructured lipid carrier (NLC)-loaded bifendate (DDB) was prepared by melt-emulsification method to improve drug payloads and… Expand
2006
2006
Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice.
Effects of bifendate, a synthetic intermediate of schisandrin C (a dibenzocyclooctadiene derivative), on liver lipid contents… Expand
2006
2006
High doses of bifendate elevate serum and hepatic triglyceride levels in rabbits and mice: animal models of acute hypertriglyceridemia
AbstractAim:To investigate the effects of bifendate on serum and hepatic lipids level in rabbits and mice.Methods:Animals were… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
2002
2002
[Anti-HBV efficacy of bifendate in treatment of chronic hepatitis B, a primary study].
OBJECTIVE To investigate the anti-HBV efficacy of bifendate in treatment of chronic hepatitis B. METHODS A total of 119… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE